KILITCH
Start SIP
Invest Now
Start SIP in KILITCH
Performance
- Low
- ₹321
- High
- ₹340
- 52 Week Low
- ₹294
- 52 Week High
- ₹500
- Open Price₹340
- Previous Close₹337
- Volume20,429
Investment Returns
- Over 1 Month -14.8%
- Over 3 Month -12.58%
- Over 6 Month -25.58%
- Over 1 Year -1.95%
Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!
Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 565
- P/B Ratio
- Average True Range
- 13.64
- EPS
- 15.77
- Dividend Yield
- 0
- MACD Signal
- -6.69
- RSI
- 27.65
- MFI
- 19.47
Kilitch Drugs(I) Financials
Kilitch Drugs(I) Technicals
EMA & SMA
Current Price
₹323.35
-13.25
(-3.94%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹350.66
- 50 Day
- ₹362.23
- 100 Day
- ₹372.35
- 200 Day
- ₹372.11
Resistance and Support
328.07
- R3 353.53
- R2 346.62
- R1 334.98
- S1 316.43
- S2 309.52
- S3 297.88
Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-07-02 | Others | Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-. |
| 2025-05-19 | Audited Results | |
| 2025-02-11 | Quarterly Results |
Kilitch Drugs(I) F&O
About Kilitch Drugs(I)
- NSE Symbol
- KILITCH
- BSE Symbol
- 524500
- Managing Director
- Mr. Mukund P Mehta
- ISIN
- INE729D01010
Similar Stocks to Kilitch Drugs(I)
Kilitch Drugs(I) FAQs
Kilitch Drugs(I) share price is ₹323 As on 09 December, 2025 | 01:14
The Market Cap of Kilitch Drugs(I) is ₹565.2 Cr As on 09 December, 2025 | 01:14
The P/E ratio of Kilitch Drugs(I) is 20.5 As on 09 December, 2025 | 01:14
The PB ratio of Kilitch Drugs(I) is 2.2 As on 09 December, 2025 | 01:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.